|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 496.35 INR | +0.02% |
|
-7.00% | +12.46% |
| 23/05 | Unichem Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| 22/05 | Unichem Laboratories March-quarter consol profit 109.1 million rupees | RE |
| Market Cap | 34.95B 367M 318M 298M 273M 515M 522M 3.49B 1.37B 17.46B 1.38B 1.35B 58.11B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 37.05B 389M 338M 316M 289M 546M 553M 3.7B 1.45B 18.51B 1.46B 1.43B 61.62B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +0.02% | ||
| 1 week | -7.00% | ||
| Current month | -3.41% | ||
| 1 month | +4.87% | ||
| 3 months | +31.80% | ||
| 6 months | +15.42% | ||
| Current year | +12.46% |
| 1 week | 493.05 |  | 525.15 |
| 1 month | 455.3 | | 685.95 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.02% | -7.00% | -7.90% | +25.47% | 367M | |
| +0.80% | +1.96% | +57.77% | +159.33% | 1,043B | |
| -0.48% | +0.21% | +50.27% | +48.09% | 621B | |
| -1.31% | -5.56% | +23.84% | +61.70% | 435B | |
| 0.00% | +3.20% | +46.70% | +37.70% | 361B | |
| +0.58% | -1.26% | +35.52% | +39.32% | 293B | |
| -1.55% | -6.84% | +7.20% | +8.86% | 251B | |
| -1.37% | +3.69% | +41.19% | +58.90% | 220B | |
| -0.24% | -11.27% | +1.42% | -46.20% | 201B | |
| -1.93% | -1.42% | +17.35% | +60.42% | 164B | |
| Average | -0.49% | -4.13% | +27.34% | +45.36% | 358.95B | |
| Weighted average by Cap. | -0.21% | -3.79% | +39.87% | +73.50% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 222M 192M 180M 165M 311M 315M 2.11B 827M 10.55B 832M 814M 35.11B | 22.02B 231M 201M 188M 172M 324M 329M 2.2B 862M 11B 868M 849M 36.62B |
| Net income | 1.38B 14.44M 12.53M 11.73M 10.73M 20.26M 20.52M 137M 53.86M 687M 54.2M 53.03M 2.29B | 2.53B 26.54M 23.03M 21.57M 19.73M 37.25M 37.73M 252M 99.02M 1.26B 99.66M 97.49M 4.2B |
| Net Debt | 3.7B 38.86M 33.72M 31.58M 28.89M 54.53M 55.25M 369M 145M 1.85B 146M 143M 6.16B | 2.11B 22.12M 19.19M 17.97M 16.44M 31.03M 31.44M 210M 82.51M 1.05B 83.04M 81.23M 3.5B |
Employees
2,780
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/08/26 | INR 496.35 | +0.02% | 4,410 |
| 05/08/26 | INR 496.25 | -0.69% | 2,971 |
| 04/08/26 | INR 499.70 | -1.08% | 1,884 |
| 03/08/26 | INR 505.15 | -1.69% | 2,866 |
| 31/07/26 | INR 513.85 | -1.79% | 2,082 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
